F. Gamma

Discipline

Psychologie (3)

Type de document

Articles (11)

Co-auteur

Date

Source

Mot-clé

risque (11) Risk (11) Patients (9) Patients (9) cohorte (9) Treatment (8) poids (7) Weight gain (7) Human beings (7) Weight (7) Cholesterol (6) Body mass index (6) évolution (5) Swiss (5) Psychotropic drugs (5) Glucose (5) Evolution (5) Metabolic syndrome (5) Evolution (5) âge (4) prescription (4) Psychotherapy patients (4) Population (4) Months (4) Blood pressure (4) Age (4) Age (4) Influence (4) Population (4) association (3)

Documents écrit par F. Gamma (11) | parle de F. Gamma (0)

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
J. Sjaarda et al.
Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study.
M. Piras et al. (3 janv. 2023)
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
B.I. Perry et al.
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
N. Laaboub et al. (17 mai 2022)
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.
M. Piras et al. (9 mai 2022)
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
G. Schoretsanitis et al.
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study.
C. Dubath et al.
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population.
A. Delacrétaz et al.
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
N. Laaboub et al. (2021)
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland.
C. Dubath et al. (31 mars 2020)
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.
A. Delacrétaz et al. (10 sept. 2017)